HQIC Antibiotic Stewardship Workgroup- Clostridioides difficile Module

Prepared by IPRO QIN/QIO

Video interview with a nurse describing her own C.  difficile survival story. The story includes a first-person accounting of her yearlong hospitalization, the impact of antibiotic therapy, prevention of C. difficile and the long-term effects of this devastating antibiotic adverse event.

Implementing Antimicrobial Stewardship and C.difficile Prevention Toolkit

The Hospital and Healthsystem Association of Pennsylvania
Quality Initiatives Department Health Care Associated
Infection Prevention Managers
.

Antibiotics represent the greatest risk factor for the development of CDI. While appropriate for treatment of many infectious diseases, antibiotics are often overused and misused. Antibiotics disturb normal bowel flora and place the patient at risk of acquiring Clostridioides difficile colonization and/or infection. Antibiotic Stewardship Programs (ASP) have been shown to be an integral part of a CDI reduction program.

The purpose of this toolkit is help facilities incorporate evidence-based research into their practices and measure their effectiveness. Process and outcome measures will be collected and trended.

Strategies to Prevent Clostridioides difficile Infection in Acute Care Facilities

Centers for Disease Control (CDC)

Provides information on the basic principles and interventions recommended for the prevention of Clostridioides (formerly known as Clostridium) difficile infection (CDI) in acute care facilities. The strategies are intended to facilitate implementation of CDI prevention efforts by state and local health departments, quality improvement organizations, hospital associations, and healthcare facilities. Core strategies for the prevention of CDI in acute care facilities include:

1. Isolate & Initiate Contact Precautions

2. Confirm CDC in Patients

3. Perform Environmental Cleaning

4. Develop Infrastructure

5. Engage the Facility Antibiotic Stewardship Program

Laboratory Assessment – Targeted Assessment for Prevention (TAP) Facility Assessment Tool; Clostridium difficile Infection (CDI)

Centers for Disease Control (CDC)

The questions in this section are laboratory-specific and should be directed to the facility’s laboratory director or other staff that have knowledge of the
practices at the laboratory that performs the facility’s C. difficile testing.